Buscar
Mostrando ítems 1-1 de 1
Artículo
In vitro activity of cefiderocol and comparators against isolates of Gram-negative bacterial pathogens from a range of infection sources: SIDERO‑WT‑2014−2018 studies in Spain
(Science Direct, 2021-07-15)
Objectives: The incidence of antimicrobial resistance in Europe is rising. Cefiderocol is approved in Eu- rope for treatment of aerobic Gram-negative bacterial (GNB) infections in adults with limited treatment options. ...